Science
Mechanism of Action
This biomimetic peptide functions by mimicking Transforming Growth Factor beta (TGFβ), a vital cytokine central to skin recovery, wound healing, and immune defense. It stimulates skin fibroblasts to enhance the production of collagen, elastin, and other extracellular matrix (ECM) components. This process revitalizes dermal cell metabolism, contributing to a rejuvenated, firmer, and noticeably smoother skin texture.
Research
Clinical Evidence
Medium confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Acetyl Heptapeptide-9 is a synthetic seven-amino acid peptide, specifically modified through N-terminal acetylation to improve its stability and compatibility within topical formulation systems. It is supplied as a lyophilized powder, exhibiting excellent solubility in water, facilitating straightforward incorporation into aqueous phases, serums, and emulsions. Formulators should note that, like other peptides, its efficacy may be compromised by exposure to strong acids (e.g., glycolic acid) and highly alkaline environments, which can denature its structure.
Conflicts
- Strong acids (e.g., glycolic acid)
- Highly alkaline ingredients
- Vitamin C (consider separate application times)
Safety
Safety Profile
Specific safety assessments from regulatory bodies such as CIR, SCCS, or FDA for Acetyl Heptapeptide-9 are not currently available. While adverse reactions are relatively uncommon, preliminary patch testing is advised before widespread use. Data on topical application during pregnancy or breastfeeding is insufficient, and consultation with a healthcare professional is recommended for individuals in these circumstances.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Acetyl Heptapeptide-9 is a valuable biomimetic peptide, clinically shown to reduce wrinkles by 55% through stimulating collagen and elastin, exhibiting low irritancy and broad compatibility across all skin types.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources